The term “cachexia” is derived from the Greek words kakos (bad) and hexis (habit).
Cachexia is a malnutrition associated with chronic diseases such as cancer, chronic heart …

Fatigue has been the most distressing and frequent symptom in breast cancer (BC) survivors
after treatment. Although fatigue can occur in other cancer survivors, women with a history of …

Cachexia remains an underdiagnosed and undertreated, complex condition which includes
'objective'components (eg inadequate food intake, weight loss, inactivity, loss of muscle …

Highlights•This ESMO Guideline provides key recommendations on the role of PROMs
during the care of patients with cancer.•It covers the use of PROMs in patients with cancer …

Introduction Neo/adjuvant therapy for early-stage breast cancer has become increasingly
common in the last few decades; as a consequence, the number of breast cancer survivors …

In palliative care (PC), the term 'end of life'(EoL) is commonly used but inconsistently
defined. 1 This European Society for Medical Oncology (ESMO) Clinical Practice Guideline …

Great efforts are being made in cancer treatment, with impressive improvement in survival.
The situation concerning research and care for long‐term problems and late effects in the …

Despite the importance of chemotherapy-associated adverse events in oncology practice
and the broad range of interventions available to mitigate them, limited systematic efforts …

Introduction The antibody-drug conjugate trastuzumab deruxtecan (T-DXd) targets human
epidermal growth factor receptor 2 (HER2) and has been evaluated in patients with HER2 …

Background & Aims Patients with early-onset colorectal cancer (eoCRC) are managed
according to guidelines that are not age-specific. A multidisciplinary international group …